Related Experiment Video
Updated: Jan 13, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition
Anita Cassoli Cortez1, Maria Cristina Nunez Seiwald1, Ana Rita Brito Medeiros da Fonseca1
1Bone Marrow Transplantation Department, Sírio Libanês Hospital, São Paulo, Brazil.
Introduction:
Allogeneic bone marrow transplantation can lead to various pulmonary complications, including acute fibrinous organizing pneumonia. This condition is rare and presents with aggressive clinical features, distinct from other forms of organizing pneumonia, such as cryptogenic organizing pneumonia.
Method:
A literature review using the PubMed, Embase, Lilacs, and Cochrane databases was conducted to analyze cases of acute fibrinous organizing pneumonia following transplantation focusing on clinical features, therapeutic approaches, and outcomes.
Case Report:
The case of a 62-year-old female who developed acute fibrinous organizing pneumonia after transplantation for acute myeloid leukemia is presented. Despite an initial absence of infectious agents, parainfluenza virus was later identified in a bronchoalveolar lavage. The patient progressed to severe hypoxemic respiratory failure and was unresponsive to corticosteroids and rituximab, ultimately dying seven months post-transplant.
Conclusion:
This is a rare and severe complication following allogeneic bone marrow transplantation. Early diagnosis, histopathological confirmation, and prompt initiation of corticosteroid therapy are critical for improving outcomes. Patients diagnosed before Day +100 generally have a better response to treatment and more favorable clinical outcomes. The need for a more effective and targeted treatment strategy remains an unmet challenge in managing this condition.
Insights
Acute fibrinous organizing pneumonia is a rare, severe complication after allogeneic bone marrow transplantation. Early diagnosis and corticosteroid treatment improve outcomes, especially when initiated before Day +100.
Area of Science:
- Pulmonary Medicine
- Hematology
- Transplantation Immunology
Background:
- Allogeneic bone marrow transplantation (BMT) can cause pulmonary complications.
- Acute fibrinous organizing pneumonia (AFOP) is a rare but severe complication post-BMT.
- AFOP presents aggressively, differing from cryptogenic organizing pneumonia.
Purpose of the Study:
- To review the literature on AFOP following BMT.
- To analyze clinical features, treatments, and outcomes of AFOP post-BMT.
- To present a case of AFOP post-BMT.
Main Methods:
- Literature search of PubMed, Embase, Lilacs, and Cochrane databases.
- Analysis of clinical data, therapeutic interventions, and patient outcomes.
- Case report of a patient with AFOP post-BMT for acute myeloid leukemia.
Main Results:
- The reviewed literature highlights AFOP as a severe post-BMT complication.
- A case presented with severe hypoxemic respiratory failure, unresponsive to standard treatments.
- Parainfluenza virus was identified, complicating the clinical picture.
Conclusions:
- Early diagnosis and prompt corticosteroid therapy are crucial for better outcomes in AFOP post-BMT.
- Treatment before Day +100 is associated with improved patient response and prognosis.
- Developing more effective, targeted treatments for AFOP remains a significant challenge.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pneumonia III: Complications and Assessment
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

